NCT00775632: Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants |
|
|
| Completed | 2 | 78 | Canada | Alemtuzumab, mycophenolate or cyclosporine and methotrexate | University Health Network, Toronto, Bayer | Graft Versus Host Disease, Bone Marrow Transplantation | 09/10 | 09/10 | | |
